Supporting scientists through the collaborative development of next generation chromatography and mass spectrometry solutions in Pharma/Biopharma and Food/Beverage Industries WALTHAM, Mass., Sept. 20, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc., the world leader in serving science, today announced its intent to open multiple Global Customer Solution Centers. The new Global Customer Solution Centers will focus... Read more
New license agreements for CRISPR technology from Broad Institute and ERS Genomics extend industry-leading genome editing capabilities CARLSBAD, Calif., Sept. 18, 2018 /PRNewswire/ — Thermo Fisher Scientific, Inc., the world leader in serving science, has licensed CRISPR technologies from the Broad Institute and ERS Genomics (foundational University of California IP) to bolster its genome editing... Read more
Thermo Scientific VetDrugs Explorer Collection provides LC-MS/MS-based solution for multi-class veterinary drug residues in sample matrices SAN JOSE, Calif., Sept. 17, 2018 /PRNewswire/ — Food scientists can now take advantage of a newly-launched, start-to-finish solution that offers robust, reliable and sensitive analysis of multi-residue veterinary drugs in complex animal-derived sample matrices, helping identify animal and dairy... Read more
FRANKLIN LAKES, N.J., Sept. 7, 2018 /PRNewswire/ — BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued the following statement regarding the sale of its Advanced Bioprocessing business to Thermo Fisher Scientific: “The sale of our Advanced Bioprocessing business will create greater focus for our Life Sciences segment where BD... Read more
End-to-end workflow analyzes safety, purity and potency of cannabis to help meet Health Canada’s testing standards Niagara Falls, Canada – Grow Up 2018 – (September 7, 2018) – With the updates to Canada’s cannabis laws set for implementation in October 2018, scientists operating within this highly regulated, growing market can now access an end-to-end analytical... Read more
WALTHAM, Mass., Sept. 7, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors has authorized the repurchase of $2.0 billion of shares of its common stock in the open market or in negotiated transactions. The authorization has no expiration date. The company’s... Read more
WALTHAM, Mass., Sept. 6, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, has signed a definitive agreement with BD (Becton, Dickinson and Company – NYSE: BDX), a leading global medical technology company, under which Thermo Fisher will acquire BD’s Advanced Bioprocessing business. This business combines a strong technical... Read more
Thermo Fisher Scientific to Showcase Latest Advances in Tumor Mutation Burden at ECP European Immuno-Oncology Consortium to present update on TMB standardization efforts and clinical research data derived from new Oncomine Tumor Mutation Load Assay workflow CARLSBAD, Calif., Sept. 6, 2018 /PRNewswire/ — Thermo Fisher Scientific will host a symposium featuring customer presentations that highlight the... Read more
Collaborating with customers to design unique bioprocessing solutions delivering optimal performance BOSTON, Sept. 4, 2018 /PRNewswire/ — BioProcess International Conference & Exhibition – Thermo Fisher Scientific, the world leader in serving science, today announced the products and solutions it will feature at the BioProcess International Conference & Exhibition (BPI) exhibit in the John B. Hynes... Read more
WALTHAM, Mass., Sept. 4, 2018 /PRNewswire/ — Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, president and chief executive officer, will present at the Morgan Stanley Global Healthcare Conference on Wednesday, September 12, 2018, at 2:15 p.m. (ET) at the Grand Hyatt New York, New York. You... Read more